A dated record of independent research-peptide test results, vendor status changes and newly certified batches, assembled automatically from named public records and published as they appear. Each entry links the record it quotes so it can be checked without trusting this site.

Where do the test results come from?

Failed tests and daily counts are quoted from Finnrick, an independent peptide-testing platform that publishes its laboratory results and the certificate behind each one under a stated methodology. Vendor status lines are quoted from the same record. Lyra Vital's own entries are our certificates from Janoshik Analytical, each carrying the laboratory's verification key.

Does a failed test mean a vendor is bad?

No. It means one sample, on one date, did not meet the standard the testing platform applies. Vendors can and do pass other tests, and the platform publishes corrections when it changes a result. Read the linked record, including the vendor's full history, before drawing any conclusion.

Why does Lyra Vital publish other vendors' results?

Because the question every buyer actually has is whether a specific batch from a specific vendor is what it claims to be, right now, and the answer lives in public records that are scattered and easy to miss. Our own certificates sit in the same list, under the same rules, which is the only honest way to publish it.

Public record

Batch Watch

What the public record says about research-peptide vendors and batches, as it happens: independent tests that did not meet a published standard, vendors whose status changed, and every batch of ours that a laboratory certified. Each entry quotes a named source and links it. We characterise nothing.

Did not meet standard: 114Daily count: 14Certificate published: 162

Alerts by email

One message a week with the entries added since the last, nothing else. No discount codes, no product pushes. Unsubscribe in one click.

Sun, Sep 20, 2026

Did not meet standard
Retatrutide from XTP did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from XTP (stated 30 mg, batch XTP-R30-003) tested 20 Sep 2026 at PharmLabs: purity 82.23%, measured 26.55 mg (-12% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Apollo Peptide Sciences did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Apollo Peptide Sciences (stated 10 mg, batch B626020L) tested 20 Sep 2026 at PharmLabs: purity 99.29%, measured 10.36 mg (+4% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Semaglutide from Apollo Peptide Sciences did not meet Finnrick's public standard
Finnrick's public record lists a Semaglutide sample from Apollo Peptide Sciences (stated 10 mg, batch PL0626S10) tested 20 Sep 2026 at PharmLabs: purity 99.44%, measured 10.53 mg (+5% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Semaglutide→
Did not meet standard
Ipamorelin from Hydro Research did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Hydro Research (stated 5 mg, batch HR-20263915) tested 20 Sep 2026 at PharmLabs: purity 99.9%, measured 7 mg (+40% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
CJC-1295 from Hydro Research did not meet Finnrick's public standard
Finnrick's public record lists a CJC-1295 sample from Hydro Research (stated 5 mg, batch HR-20266208) tested 20 Sep 2026 at PharmLabs: purity 89.98%, measured 7.15 mg (+43% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for CJC-1295→
Did not meet standard
BPC-157 from Hydro Research did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Hydro Research (stated 5 mg, batch HR-20264512) tested 20 Sep 2026 at PharmLabs: purity 98.67%, measured 5.34 mg (+7% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
BPC-157 from Reta-Peptide did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Reta-Peptide (stated 5 mg, batch Jan 26 2026) tested 20 Sep 2026 at PharmLabs: purity 99.34%, measured 5 mg (0% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
BPC-157 from Apollo Peptide Sciences did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Apollo Peptide Sciences (stated 10 mg, batch BL0426B) tested 20 Sep 2026 at PharmLabs: purity 98.88%, measured 9.74 mg (-3% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from Nexaph did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Nexaph (stated 10 mg, batch NXP-2P1004162026-03) tested 20 Sep 2026 at PharmLabs: purity 98.25%, measured 11.94 mg (+19% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Retatrutide from XTP did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from XTP (stated 30 mg, batch XTP-R30-003) tested 20 Sep 2026 at PharmLabs: purity 82.64%, measured 24.42 mg (-19% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 16 tests on 2026-09-20: 6 met the public standard, 10 did not
On 2026-09-20 Finnrick published 16 independent laboratory tests across its vendor record. 6 met its public Purity Focus standard, 10 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Wed, Sep 16, 2026

Daily count
Finnrick published 1 test on 2026-09-16: 0 met the public standard, 0 did not
On 2026-09-16 Finnrick published 1 independent laboratory test across its vendor record. 0 met its public Purity Focus standard, 0 did not, 1 could not be classified. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Mon, Sep 14, 2026

Daily count
Finnrick published 5 tests on 2026-09-14: 5 met the public standard, 0 did not
On 2026-09-14 Finnrick published 5 independent laboratory tests across its vendor record. 5 met its public Purity Focus standard, 0 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Thu, Sep 10, 2026

Did not meet standard
Tirzepatide from LP Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from LP Peptide (stated 30 mg, batch TR3026060201) tested 10 Sep 2026 at Krause Analytical: purity 65.4%, measured 19.7 mg (-34% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tesamorelin from Heman Peptide HM did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Heman Peptide HM (stated 10 mg, batch Aug.06,2026) tested 10 Sep 2026 at Krause Analytical: purity 95.1%, measured 8.45 mg (-16% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Tesamorelin from Yiwu Aozuo Trading Co did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Yiwu Aozuo Trading Co (stated 10 mg, batch 23/05/2026) tested 10 Sep 2026 at Krause Analytical: purity 98.6%, measured 9.13 mg (-9% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
MOTS-c from Heman Peptide HM did not meet Finnrick's public standard
Finnrick's public record lists a MOTS-c sample from Heman Peptide HM (stated 20 mg, batch Jun.20,2026) tested 10 Sep 2026 at Krause Analytical: purity 98.5%, measured 23 mg (+15% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for MOTS-c→
Did not meet standard
TB-500 from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from HK Peptides (stated 10 mg, batch March 17 2026) tested 10 Sep 2026 at Krause Analytical: purity 98%, measured 9.63 mg (-4% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
Tirzepatide from Mia Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Mia Peptide (stated 10 mg, batch CP01260627110X) tested 10 Sep 2026 at Krause Analytical: purity 69.5%, measured 7.11 mg (-29% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Ipamorelin from Yiwu Aozuo Trading Co did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Yiwu Aozuo Trading Co (stated 5 mg, batch 18/04/2026) tested 10 Sep 2026 at Krause Analytical: purity 99.2%, measured 5 mg (0% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
Tesamorelin from EHZ Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from EHZ Peptides (stated 10 mg, batch Mfg July 3, 2026) tested 10 Sep 2026 at Krause Analytical: purity 95.9%, measured 8.41 mg (-16% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
NAD+ from Heman Peptide HM did not meet Finnrick's public standard
Finnrick's public record lists a NAD+ sample from Heman Peptide HM (stated 1000 mg, batch July.18,2026) tested 10 Sep 2026 at Krause Analytical: purity 98.1%, measured 469 mg (-53% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for NAD+→
Did not meet standard
Tirzepatide from Kerui Peptide HongKong did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Kerui Peptide HongKong (stated 30 mg, batch May 2026 (Blue Top)) tested 10 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tesamorelin from Nexaph did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Nexaph (stated 10 mg, batch TES1003212026-20) tested 10 Sep 2026 at Krause Analytical: purity 99%, measured 9.53 mg (-5% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Daily count
Finnrick published 17 tests on 2026-09-10: 6 met the public standard, 11 did not
On 2026-09-10 Finnrick published 17 independent laboratory tests across its vendor record. 6 met its public Purity Focus standard, 11 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Wed, Sep 9, 2026

Did not meet standard
Retatrutide from Novabio Research did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Novabio Research (stated 15 mg, batch Mar 2026) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from XTP did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from XTP (stated 30 mg, batch XTP-R30-003) tested 9 Sep 2026 at Krause Analytical: purity 91.9%, measured 21.6 mg (-28% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Changsha Caoquan Technology did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Changsha Caoquan Technology (stated 40 mg, batch Mfg: May 2026) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Peptide Healths did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Peptide Healths (stated 10 mg, batch 16/03/2026) tested 9 Sep 2026 at Krause Analytical: purity 77.9%, measured 6.76 mg (-32% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from LP Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from LP Peptide (stated 20 mg, batch PED26050802) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
GHK-Cu from Peptide Partners did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Peptide Partners (stated 100 mg, batch CU202604) tested 9 Sep 2026 at Krause Analytical: purity 99.9%, measured 137 mg (+37% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
GHK-Cu from EHZ Peptides did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from EHZ Peptides (stated 100 mg, batch CU1000701) tested 9 Sep 2026 at Krause Analytical: purity 99.9%, measured 60.7 mg (-39% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
Retatrutide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from HK Peptides (stated 10 mg, batch 2381089-83-2) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
BPC-157 from Yabang Peptide did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Yabang Peptide (stated 10 mg, batch April 2, 2026) tested 9 Sep 2026 at Krause Analytical: purity 99%, measured 9.84 mg (-2% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
CJC-1295 from LiliPeptide did not meet Finnrick's public standard
Finnrick's public record lists a CJC-1295 sample from LiliPeptide (stated 10 mg, batch CP10/260403) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for CJC-1295→
Did not meet standard
Retatrutide from Lumira did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Lumira (stated 20 mg, batch WP-RT20-P00043) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Yabang Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Yabang Peptide (stated 10 mg, batch Apr 28, 2026) tested 9 Sep 2026 at Krause Analytical: purity 98.3%, measured 8.05 mg (-20% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from LP Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from LP Peptide (stated 20 mg, batch RET-26031501) tested 9 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
GHK-Cu from LP Peptide did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from LP Peptide (stated 100 mg, batch 26030904) tested 9 Sep 2026 at Krause Analytical: purity 99.9%, measured 13.1 mg (-87% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
Retatrutide from Shanghai Leader Peptide Biotechnology did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Shanghai Leader Peptide Biotechnology (stated 20 mg, batch RT20-04-26) tested 9 Sep 2026 at Krause Analytical: purity 92.5%, measured 12.3 mg (-39% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 44 tests on 2026-09-09: 29 met the public standard, 15 did not
On 2026-09-09 Finnrick published 44 independent laboratory tests across its vendor record. 29 met its public Purity Focus standard, 15 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Tue, Sep 8, 2026

Did not meet standard
Retatrutide from Novabio Research did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Novabio Research (stated 20 mg) tested 8 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 13 tests on 2026-09-08: 12 met the public standard, 1 did not
On 2026-09-08 Finnrick published 13 independent laboratory tests across its vendor record. 12 met its public Purity Focus standard, 1 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Mon, Sep 7, 2026

Did not meet standard
Retatrutide from Rayshine Peptide Biochemicals did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Rayshine Peptide Biochemicals (stated 20 mg, batch 2026.06.03) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Yiwu Beigong did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Yiwu Beigong (stated 50 mg, batch Jul, 2026) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Zztai Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Zztai Peptide (stated 30 mg, batch June 2026) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Norco did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Norco (stated 10 mg, batch 2006-6-18) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from NutriPeptix did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from NutriPeptix (stated 10 mg, batch 6/26/2026) tested 7 Sep 2026 at BTLabs: purity 81%, measured 6.2 mg (-38% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Noble Dragons did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Noble Dragons (stated 15 mg, batch RET-26031501) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Tirzepatide from Lumira did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Lumira (stated 30 mg, batch WP-TR30-000041) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tirzepatide from Zhengzhou Lan Yun Cosmetic Trading did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Zhengzhou Lan Yun Cosmetic Trading (stated 60 mg) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Retatrutide from Zhengzhou Lan Yun Cosmetic Trading did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Zhengzhou Lan Yun Cosmetic Trading (stated 30 mg) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Norco did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Norco (stated 10 mg, batch 260121-BZT-RT10-01-P) tested 7 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 26 tests on 2026-09-07: 15 met the public standard, 10 did not
On 2026-09-07 Finnrick published 26 independent laboratory tests across its vendor record. 15 met its public Purity Focus standard, 10 did not, 1 could not be classified. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Sat, Sep 5, 2026

Did not meet standard
Tesamorelin from Laicuinuo LCN did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Laicuinuo LCN (stated 10 mg, batch JUNE12026 LOT:260723) tested 5 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Retatrutide from Laicuinuo LCN did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Laicuinuo LCN (stated 20 mg, batch JUNE012026 LOT260721) tested 5 Sep 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 18 tests on 2026-09-05: 15 met the public standard, 2 did not
On 2026-09-05 Finnrick published 18 independent laboratory tests across its vendor record. 15 met its public Purity Focus standard, 2 did not, 1 could not be classified. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Fri, Sep 4, 2026

Did not meet standard
Tirzepatide from Core Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Core Peptides (stated 20 mg, batch TR20-07-610) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
TB-500 from Bionexis Peptides did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Bionexis Peptides (stated 5 mg, batch 907ATS) tested 4 Sep 2026 at Krause Analytical: purity 98.6%, measured 5.44 mg (+9% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
TB-500 from Bionexis Peptides did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Bionexis Peptides (stated 5 mg, batch 907ATS) tested 4 Sep 2026 at Krause Analytical: purity 99.3%, measured 5.32 mg (+6% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
BPC-157 from Peptide Crafters did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Peptide Crafters (stated 10 mg, batch pc-g2-bp10) tested 4 Sep 2026 at Krause Analytical: purity 98.3%, measured 10.3 mg (+3% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Sermorelin from Qing Li Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Sermorelin sample from Qing Li Peptide (stated 10 mg, batch July 1 2026) tested 4 Sep 2026 at Krause Analytical: purity 98%, measured 9.07 mg (-9% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→
Did not meet standard
GHK-Cu from Super panda peptide did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Super panda peptide (stated 100 mg) tested 4 Sep 2026 at Krause Analytical: purity 99.3%, measured 108 mg (+8% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
GHK-Cu from Bionexis Peptides did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Bionexis Peptides (stated 50 mg, batch 827VMS) tested 4 Sep 2026 at Krause Analytical: purity 99.9%, measured 75.3 mg (+51% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
Sermorelin from Shanxi Qianyecao Biotech QYC did not meet Finnrick's public standard
Finnrick's public record lists a Sermorelin sample from Shanxi Qianyecao Biotech QYC (stated 5 mg, batch Qy3600smo5) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→
Did not meet standard
MOTS-c from ZePeptide did not meet Finnrick's public standard
Finnrick's public record lists a MOTS-c sample from ZePeptide (stated 10 mg, batch Jul 11, 2026) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for MOTS-c→
Did not meet standard
Ipamorelin from Wuhan Wansheng Biotechnology did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Wuhan Wansheng Biotechnology (stated 10 mg, batch IP10) tested 4 Sep 2026 at Krause Analytical: purity 98.2%, measured 10.6 mg (+6% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
Retatrutide from Mokemei Zhengzhou Biotechnology MKM did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Mokemei Zhengzhou Biotechnology MKM (stated 30 mg, batch 20260623-2) tested 4 Sep 2026 at Krause Analytical: purity 35.4%, measured 4.57 mg (-85% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
KPV from Shanghai Baoju did not meet Finnrick's public standard
Finnrick's public record lists a KPV sample from Shanghai Baoju (stated 10 mg, batch June 23, 2026) tested 4 Sep 2026 at Krause Analytical: purity 99%, measured 10.5 mg (+5% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for KPV→
Did not meet standard
HGH from Lumira did not meet Finnrick's public standard
Finnrick's public record lists a HGH sample from Lumira (stated 24 IU, batch WP-H24iu-P00043) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→
Did not meet standard
Tirzepatide from Crestpeptide did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Crestpeptide (stated 10 mg, batch March 6 2026) tested 4 Sep 2026 at Krause Analytical: purity 98.1%, measured 9.36 mg (-6% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tirzepatide from Unicorn Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Unicorn Peptide (stated 50 mg, batch Gz260708-04) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Ipamorelin from Peptide Crafters did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Peptide Crafters (stated 10 mg, batch pc-g1-ip10) tested 4 Sep 2026 at Krause Analytical: purity 98.8%, measured 10.2 mg (+2% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
GHK-Cu from Rethel Jinan New Energy Technology did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Rethel Jinan New Energy Technology (stated 100 mg, batch May 2, 2025) tested 4 Sep 2026 at Krause Analytical: purity 99.9%, measured 53.9 mg (-46% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
GHK-Cu from Bionexis Peptides did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Bionexis Peptides (stated 50 mg, batch 827VMS) tested 4 Sep 2026 at Krause Analytical: purity 99.3%, measured 75.4 mg (+51% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
GHK-Cu from Simple Peptide did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from Simple Peptide (stated 100 mg, batch GHK100-032026-4) tested 4 Sep 2026 at Krause Analytical: purity 98.3%, measured 134 mg (+34% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
KPV from Homopeptide did not meet Finnrick's public standard
Finnrick's public record lists a KPV sample from Homopeptide (stated 10 mg, batch Mar 2 2026) tested 4 Sep 2026 at Krause Analytical: purity 98.3%, measured 9.97 mg (-0% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for KPV→
Did not meet standard
TB-500 from Peptide Crafters did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Peptide Crafters (stated 10 mg, batch pc-g3-tb10) tested 4 Sep 2026 at Krause Analytical: purity 99.1%, measured 9.73 mg (-3% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
Tirzepatide from Wuhan Wansheng Biotechnology did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Wuhan Wansheng Biotechnology (stated 10 mg, batch TR10WWB062026) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Sermorelin from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Sermorelin sample from HK Peptides (stated 10 mg, batch June 18 2026) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→
Did not meet standard
BPC-157 from TSC Top Supplements China did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from TSC Top Supplements China (stated 10 mg, batch 258019) tested 4 Sep 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Daily count
Finnrick published 61 tests on 2026-09-04: 37 met the public standard, 24 did not
On 2026-09-04 Finnrick published 61 independent laboratory tests across its vendor record. 37 met its public Purity Focus standard, 24 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Thu, Sep 3, 2026

Did not meet standard
TB-500 from Reta-Peptide did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Reta-Peptide (stated 5 mg, batch Jan 5, 2025) tested 3 Sep 2026 at PharmLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
TB-500 from Hydro Research did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Hydro Research (stated 10 mg, batch HR-20269422) tested 3 Sep 2026 at PharmLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Did not meet standard
TB-500 from Apollo Peptide Sciences did not meet Finnrick's public standard
Finnrick's public record lists a TB-500 sample from Apollo Peptide Sciences (stated 10 mg) tested 3 Sep 2026 at PharmLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for TB-500→
Daily count
Finnrick published 4 tests on 2026-09-03: 0 met the public standard, 3 did not
On 2026-09-03 Finnrick published 4 independent laboratory tests across its vendor record. 0 met its public Purity Focus standard, 3 did not, 1 could not be classified. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Mon, Aug 31, 2026

Did not meet standard
BPC-157 from Longevity Plan did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Longevity Plan (stated 10 mg) tested 31 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Retatrutide from ZePeptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from ZePeptide (stated 30 mg, batch 2026,6,19) tested 31 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Retatrutide from Tianjin StarHarbor Technology did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Tianjin StarHarbor Technology (stated 10 mg) tested 31 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
CJC-IPA from Longevity Plan did not meet Finnrick's public standard
Finnrick's public record lists a CJC-IPA sample from Longevity Plan (stated 10 mg) tested 31 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→
Daily count
Finnrick published 20 tests on 2026-08-31: 16 met the public standard, 4 did not
On 2026-08-31 Finnrick published 20 independent laboratory tests across its vendor record. 16 met its public Purity Focus standard, 4 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Fri, Aug 28, 2026

Did not meet standard
Retatrutide from Core Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Core Peptides (stated 50 mg, batch Rt50) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Ipamorelin from Pura Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Pura Peptides (stated 10 mg, batch IPAB-11725) tested 28 Aug 2026 at Ichor Life Sciences: purity 94.55%, measured 10.05 mg (+1% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
Retatrutide from Kerui Peptide HongKong did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Kerui Peptide HongKong (stated 10 mg, batch June25,2028) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
BPC-157 from Shanghai ERP peptide Biotechnology did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Shanghai ERP peptide Biotechnology (stated 10 mg, batch 990007) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from HK Peptides (stated 40 mg, batch july 2026) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Cagrilintide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Cagrilintide sample from HK Peptides (stated 5 mg, batch july 2026) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Cagrilintide→
Did not meet standard
Tirzepatide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from HK Peptides (stated 30 mg, batch july 2026) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
GHK-Cu from SaiyanMed did not meet Finnrick's public standard
Finnrick's public record lists a GHK-Cu sample from SaiyanMed (stated 50 mg, batch CU50) tested 28 Aug 2026 at BTLabs: purity 99.7%, measured 24.3 mg (-51% against the stated amount). Reason recorded: dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for GHK-Cu→
Did not meet standard
Tirzepatide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from HK Peptides (stated 60 mg, batch july 20226) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Retatrutide from Novabio Research did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Novabio Research (stated 20 mg, batch March 2026) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
BPC-157 from Longevity Plan did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Longevity Plan (stated 10 mg) tested 28 Aug 2026 at Ichor Life Sciences:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from HK Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from HK Peptides (stated 20 mg, batch jul 2026) tested 28 Aug 2026 at BTLabs:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Daily count
Finnrick published 36 tests on 2026-08-28: 23 met the public standard, 12 did not
On 2026-08-28 Finnrick published 36 independent laboratory tests across its vendor record. 23 met its public Purity Focus standard, 12 did not, 1 could not be classified. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Thu, Aug 27, 2026

Did not meet standard
Tirzepatide from Lumira did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Lumira (stated 30 mg, batch WL-TR30-P00029) tested 27 Aug 2026 at Ichor Life Sciences:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tirzepatide from Pura Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Pura Peptides (stated 10 mg, batch T10TB2226) tested 27 Aug 2026 at Ichor Life Sciences: purity 98.81%, measured 10.57 mg (+6% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
BPC-157 from Mai Peptide did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Mai Peptide (stated 10 mg, batch PVD185) tested 27 Aug 2026 at Ichor Life Sciences: purity 91.8%, measured 11.61 mg (+16% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
BPC-157 from Skye Peptides did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Skye Peptides (stated 10 mg, batch BPC26-10-001) tested 27 Aug 2026 at Ichor Life Sciences: purity 99.34%, measured 10.79 mg (+8% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tesamorelin from Skye Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Skye Peptides (stated 10 mg, batch TESA26-10-001) tested 27 Aug 2026 at Ichor Life Sciences: purity 85.23%, measured 12.72 mg (+27% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Tirzepatide from Nexaph did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Nexaph (stated 15 mg, batch NXP-2P1504032026-04) tested 27 Aug 2026 at Ichor Life Sciences: purity 97.24%, measured 17.41 mg (+16% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tirzepatide from Inno Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Inno Peptides (stated 60 mg, batch TR60/2026-03-06A) tested 27 Aug 2026 at Ichor Life Sciences: purity 95.72%, measured 69.33 mg (+16% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
BPC-157 from Crush Research did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Crush Research (stated 5 mg, batch CR-BPC) tested 27 Aug 2026 at Ichor Life Sciences: purity 87.79%, measured 8.75 mg (+75% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from ZZQ Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from ZZQ Peptides (stated 30 mg) tested 27 Aug 2026 at Ichor Life Sciences: purity 98.77%, measured 12.12 mg (-60% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
BPC-157 from Skye Peptides did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Skye Peptides (stated 10 mg, batch BPC26-10-001) tested 27 Aug 2026 at Ichor Life Sciences: purity 98.02%, measured 10.74 mg (+7% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
BPC-157 from Peptide Crafters did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Peptide Crafters (stated 10 mg, batch PC-G3-BP10) tested 27 Aug 2026 at Ichor Life Sciences: purity 91.92%, measured 9.94 mg (-1% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from Norco did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Norco (stated 20 mg, batch Lot S51 G03) tested 27 Aug 2026 at Ichor Life Sciences: purity 74.5%, measured 10.31 mg (-48% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tirzepatide from Heman Peptide HM did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Heman Peptide HM (stated 40 mg, batch Lot 258041) tested 27 Aug 2026 at Ichor Life Sciences: purity 95.97%, measured 48.9 mg (+22% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Tesamorelin from Hong Kong Meiliduo Technology Limited did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Hong Kong Meiliduo Technology Limited (stated 10 mg, batch Tsm10-07-27) tested 27 Aug 2026 at Ichor Life Sciences: purity 87.23%, measured 10.88 mg (+9% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Tesamorelin from Skye Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Skye Peptides (stated 10 mg, batch TESA26-10-001) tested 27 Aug 2026 at Ichor Life Sciences: purity 83.84%, measured 12.66 mg (+27% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Tesamorelin from Pura Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Tesamorelin sample from Pura Peptides (stated 10 mg, batch TESARB-09525) tested 27 Aug 2026 at Ichor Life Sciences: purity 96.63%, measured 11.69 mg (+17% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tesamorelin→
Did not meet standard
Ipamorelin from Skye Peptides did not meet Finnrick's public standard
Finnrick's public record lists a Ipamorelin sample from Skye Peptides (stated 10 mg, batch IPA25-10-003) tested 27 Aug 2026 at Ichor Life Sciences: purity 94.53%, measured 10.66 mg (+7% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Ipamorelin→
Did not meet standard
BPC-157 from Crush Research did not meet Finnrick's public standard
Finnrick's public record lists a BPC-157 sample from Crush Research (stated 5 mg, batch CR-BPC) tested 27 Aug 2026 at Ichor Life Sciences: purity 87.27%, measured 8.72 mg (+74% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for BPC-157→
Did not meet standard
Tirzepatide from Henan Sahe Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from Henan Sahe Peptide (stated 40 mg, batch SAHA-TR40-202605025) tested 27 Aug 2026 at Ichor Life Sciences: purity 89.23%, measured 12.81 mg (-68% against the stated amount). Reason recorded: purity below the standard's threshold; dosage deviation out of range. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Daily count
Finnrick published 19 tests on 2026-08-27: 0 met the public standard, 19 did not
On 2026-08-27 Finnrick published 19 independent laboratory tests across its vendor record. 0 met its public Purity Focus standard, 19 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Wed, Aug 26, 2026

Did not meet standard
Retatrutide from Quenna PMQ did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Quenna PMQ (stated 30 mg, batch Oct 18 2027) tested 26 Aug 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Did not meet standard
Tirzepatide from PeptideJFT did not meet Finnrick's public standard
Finnrick's public record lists a Tirzepatide sample from PeptideJFT (stated 15 mg, batch GB260803-01) tested 26 Aug 2026 at Krause Analytical: purity 98.9%, measured 14.7 mg (-2% against the stated amount). Reason recorded: purity below the standard's threshold. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Tirzepatide→
Did not meet standard
Retatrutide from Unicorn Peptide did not meet Finnrick's public standard
Finnrick's public record lists a Retatrutide sample from Unicorn Peptide (stated 5 mg, batch RT-26062) tested 26 Aug 2026 at Krause Analytical:. Reason recorded: identity not confirmed. Classified under Finnrick's public Purity Focus standard (purity at least 99.5%, fill within 35% of claim).
Source: Finnrick→ · Lyra Vital certificates for Retatrutide→
Daily count
Finnrick published 20 tests on 2026-08-26: 17 met the public standard, 3 did not
On 2026-08-26 Finnrick published 20 independent laboratory tests across its vendor record. 17 met its public Purity Focus standard, 3 did not. Every result is public on Finnrick with the laboratory certificate behind it.
Source: Finnrick→

Thu, Jul 30, 2026

Certificate published
NAD+ batch CS-na500-0710: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0710 on 2026-07-30 (measured content 633.87 mg). Laboratory verification key HEA17Y1TBSYU. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10-0714: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0714 on 2026-07-30 (HPLC purity 99.25%, measured content 20.79 mg). Laboratory verification key UCL9UBH6UKA1. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jul 29, 2026

Certificate published
Kisspeptin-10 batch CS-ki10-0710: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki10-0710 on 2026-07-29 (HPLC purity 99.82%, measured content 13.21 mg). Laboratory verification key VZJKOHUJAY7H. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jul 27, 2026

Certificate published
Tirzepatide batch CS-ze10-0707: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze10-0707 on 2026-07-27 (HPLC purity 99.63%, measured content 11.42 mg). Laboratory verification key SEPKBM9X4R1Q. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glow Blend batch CS-gw70-0704: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw70-0704 on 2026-07-27 (measured content 63.75 mg). Laboratory verification key DIJ65Z4G6PVL. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →

Thu, Jul 23, 2026

Certificate published
Semaglutide batch CS-se20-0704: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se20-0704 on 2026-07-23 (HPLC purity 99.73%, measured content 22.26 mg). Laboratory verification key CEXHF2CQ6GL6. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
CJC-1295 (no DAC) batch CS-noda10-0630: certificate published
Janoshik Analytical analysed CJC-1295 (no DAC) batch CS-noda10-0630 on 2026-07-23 (HPLC purity 99.78%, measured content 10.76 mg). Laboratory verification key XWHPQNDJNF2I. The certificate is published at https://lyravital.com/coa/cjc-1295.
Source: Janoshik Analytical→ · Certificate history →

Tue, Jul 21, 2026

Certificate published
Thymosin Alpha-1 batch CS-ta110-0626: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-ta110-0626 on 2026-07-21 (HPLC purity 99.70%, measured content 11.64 mg). Laboratory verification key N6US3SZN4W7D. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →

Tue, Jul 14, 2026

Certificate published
AOD-9604 batch CS-ad5-0625: certificate published
Janoshik Analytical analysed AOD-9604 batch CS-ad5-0625 on 2026-07-14 (HPLC purity 99.78%, measured content 5.2 mg). Laboratory verification key WQESLRYDR3HH. The certificate is published at https://lyravital.com/coa/aod-9604.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jul 13, 2026

Certificate published
Semax batch CS-sem10-0625: certificate published
Janoshik Analytical analysed Semax batch CS-sem10-0625 on 2026-07-13 (HPLC purity 99.14%, measured content 11.32 mg). Laboratory verification key WSJ58JQX3JTD. The certificate is published at https://lyravital.com/coa/semax.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Selank batch CS-sel10-0625: certificate published
Janoshik Analytical analysed Selank batch CS-sel10-0625 on 2026-07-13 (HPLC purity 99.16%, measured content 10.55 mg). Laboratory verification key KVFEJXDX9LAY. The certificate is published at https://lyravital.com/coa/selank.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re10-0625: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-0625 on 2026-07-13 (HPLC purity 99.64%, measured content 11.76 mg). Laboratory verification key AKC4Q31UXR3S. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Jul 10, 2026

Certificate published
NAD+ batch CS-na1000-0625: certificate published
Janoshik Analytical analysed NAD+ batch CS-na1000-0625 on 2026-07-10 (measured content 1110.51 mg). Laboratory verification key LPQHSNIPBJLJ. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jul 1, 2026

Certificate published
Tesamorelin batch CS-te10-0616: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te10-0616 on 2026-07-01 (HPLC purity 99.17%, measured content 11.56 mg). Laboratory verification key ZKEI2BVYMMF8. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
NAD+ batch CS-na500-0609: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0609 on 2026-07-01 (measured content 573.78 mg). Laboratory verification key 2M7WHD95M8BL. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Tue, Jun 30, 2026

Certificate published
GHK-Cu batch CS-gu100-0615: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100-0615 on 2026-06-30 (HPLC purity 99.91%, measured content 108.95 mg). Laboratory verification key NL3YL2C4EDQT. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jun 29, 2026

Certificate published
BPC-157 batch CS-bc10-0615: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0615 on 2026-06-29 (HPLC purity 99.89%, measured content 11.95 mg). Laboratory verification key 7S6NKULKN73E. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jun 22, 2026

Certificate published
Tirzepatide batch CS-ze10-0603: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze10-0603 on 2026-06-22 (HPLC purity 99.71%, measured content 12.35 mg). Laboratory verification key 6EVK1G7TJD4Q. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jun 17, 2026

Certificate published
Retatrutide batch CS-re20-0603: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20-0603 on 2026-06-17 (HPLC purity 99.75%, measured content 24.81 mg). Laboratory verification key URPY32K52071. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Tue, Jun 16, 2026

Certificate published
PT-141 batch CS-pt10-0603: certificate published
Janoshik Analytical analysed PT-141 batch CS-pt10-0603 on 2026-06-16 (HPLC purity 99.02%, measured content 11.21 mg). Laboratory verification key JBAU27IV4THB. The certificate is published at https://lyravital.com/coa/pt-141.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glow Blend batch CS-gw70-0603: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw70-0603 on 2026-06-16 (measured content 61.9 mg). Laboratory verification key N9D8NHN52F3Q. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jun 15, 2026

Certificate published
Tirzepatide batch CS-ze30-0529: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze30-0529 on 2026-06-15 (HPLC purity 99.76%, measured content 33.63 mg). Laboratory verification key E88D53MTAQGG. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Thymosin Alpha-1 batch CS-ta110-0710: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-ta110-0710 on 2026-06-15 (HPLC purity 99.84%, measured content 12.11 mg). Laboratory verification key B6E1CPNYAGQR. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semaglutide batch CS-se10-0529: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se10-0529 on 2026-06-15 (HPLC purity 99.66%, measured content 11.42 mg). Laboratory verification key RDIESQFK2T7Y. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Kisspeptin-10 batch CS-ki10-0526: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki10-0526 on 2026-06-15 (HPLC purity 99.84%, measured content 13.58 mg). Laboratory verification key RLVU17G7MXPZ. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jun 10, 2026

Certificate published
Retatrutide batch CS-re10-0526: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-0526 on 2026-06-10 (HPLC purity 99.70%, measured content 11.79 mg). Laboratory verification key G8IZ6SNH3WJ4. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jun 8, 2026

Certificate published
Ipamorelin batch CS-ip10-0526: certificate published
Janoshik Analytical analysed Ipamorelin batch CS-ip10-0526 on 2026-06-08 (HPLC purity 99.67%, measured content 10.68 mg). Laboratory verification key GRG1EKYUSYQF. The certificate is published at https://lyravital.com/coa/ipamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
CJC-1295 (no DAC) batch CS-noda10-0526: certificate published
Janoshik Analytical analysed CJC-1295 (no DAC) batch CS-noda10-0526 on 2026-06-08 (HPLC purity 99.88%, measured content 10.54 mg). Laboratory verification key RJ17C8UYZLCS. The certificate is published at https://lyravital.com/coa/cjc-1295.
Source: Janoshik Analytical→ · Certificate history →

Tue, May 26, 2026

Certificate published
Thymosin Alpha-1 batch CS-gu100-0509: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-gu100-0509 on 2026-05-26 (HPLC purity 99.90%, measured content 12.31 mg). Laboratory verification key JNLJEBG2JQBG. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10-0509: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0509 on 2026-05-26 (HPLC purity 99.93%, measured content 11.32 mg). Laboratory verification key B7GL3G7GZTI3. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Fri, May 22, 2026

Certificate published
NAD+ batch CS-na500-0509: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0509 on 2026-05-22 (measured content 687.87 mg). Laboratory verification key ULD4JWGQK1WC. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Mon, May 4, 2026

Certificate published
Glow Blend batch CS-gw70-0423: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw70-0423 on 2026-05-04 (measured content 56.93 mg). Laboratory verification key KGTSZJ51CIXY. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
5-Amino-1MQ batch CS-5aq10-0415: certificate published
Janoshik Analytical analysed 5-Amino-1MQ batch CS-5aq10-0415 on 2026-05-04 (measured content 11.47 mg). Laboratory verification key lYISDYNE6B72. The certificate is published at https://lyravital.com/coa/5-amino-1mq.
Source: Janoshik Analytical→ · Certificate history →

Mon, Apr 27, 2026

Certificate published
Tirzepatide batch CS-ze10-0408: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze10-0408 on 2026-04-27 (HPLC purity 99.76%, measured content 12.13 mg). Laboratory verification key MQIPS86NBTAX. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →

Thu, Apr 23, 2026

Certificate published
Tesamorelin batch CS-te10-0408: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te10-0408 on 2026-04-23 (HPLC purity 99.68%, measured content 11.6 mg). Laboratory verification key MPW66QXY18MA. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
TB-500 batch CS-tb10-0408: certificate published
Janoshik Analytical analysed TB-500 batch CS-tb10-0408 on 2026-04-23 (HPLC purity 99.77%, measured content 11.99 mg). Laboratory verification key GXBWLBLLUZF7. The certificate is published at https://lyravital.com/coa/tb-500.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
MOTS-c batch CS-mc10-0408: certificate published
Janoshik Analytical analysed MOTS-c batch CS-mc10-0408 on 2026-04-23 (HPLC purity 99.03%, measured content 11.82 mg). Laboratory verification key HOPCKXFSN4PP. The certificate is published at https://lyravital.com/coa/mots-c.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
AOD-9604 batch CS-ad5-0408: certificate published
Janoshik Analytical analysed AOD-9604 batch CS-ad5-0408 on 2026-04-23 (HPLC purity 99.72%, measured content 5.65 mg). Laboratory verification key YCTJVR4KN3VW. The certificate is published at https://lyravital.com/coa/aod-9604.
Source: Janoshik Analytical→ · Certificate history →

Tue, Apr 14, 2026

Certificate published
Wolverine Blend batch CS-t/b55-0403: certificate published
Janoshik Analytical analysed Wolverine Blend batch CS-t/b55-0403 on 2026-04-14 (measured content 6.38 mg). Laboratory verification key 3SYUIILWURPQ. The certificate is published at https://lyravital.com/coa/wolverine-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
NAD+ batch CS-na500-0403: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0403 on 2026-04-14 (measured content 529.47 mg). Laboratory verification key 779V1TILICAS. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu100-0403: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100-0403 on 2026-04-14 (HPLC purity 99.45%, measured content 92.61 mg). Laboratory verification key 9Q35X2A58SET. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →

Fri, Apr 10, 2026

Certificate published
Tesamorelin batch CS-te10-0305: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te10-0305 on 2026-04-10 (HPLC purity 99.62%, measured content 11.65 mg). Laboratory verification key QBSEPR4JCLQJ. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
SS-31 batch CS-s310-0327: certificate published
Janoshik Analytical analysed SS-31 batch CS-s310-0327 on 2026-04-10 (HPLC purity 99.86%, measured content 10.87 mg). Laboratory verification key U6TDC4BPIVLB. The certificate is published at https://lyravital.com/coa/ss-31.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semaglutide batch CS-se10-0327: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se10-0327 on 2026-04-10 (HPLC purity 99.65%, measured content 11.5 mg). Laboratory verification key 8XPNYK8GFBC6. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Selank batch CS-sel10-0322: certificate published
Janoshik Analytical analysed Selank batch CS-sel10-0322 on 2026-04-10 (HPLC purity 99.89%, measured content 12.52 mg). Laboratory verification key WVB2B8KBLJ3W. The certificate is published at https://lyravital.com/coa/selank.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re10-0322: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-0322 on 2026-04-10 (HPLC purity 99.79%, measured content 11.86 mg). Laboratory verification key MSARBWF3I3P9. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
KPV batch CS-kv10-0305: certificate published
Janoshik Analytical analysed KPV batch CS-kv10-0305 on 2026-04-10 (HPLC purity 99.42%, measured content 13.34 mg). Laboratory verification key YIZTUESVLSKF. The certificate is published at https://lyravital.com/coa/kpv.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu100-0305: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100-0305 on 2026-04-10 (HPLC purity 99.76%, measured content 116.68 mg). Laboratory verification key BG58Z5R5U842. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ep10-0327: certificate published
Janoshik Analytical analysed Epitalon batch CS-ep10-0327 on 2026-04-10 (HPLC purity 99.46%, measured content 11.07 mg). Laboratory verification key WMT1TRTX5RXQ. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →

Thu, Apr 9, 2026

Certificate published
Retatrutide batch CS-re30-0327: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re30-0327 on 2026-04-09 (HPLC purity 99.91%, measured content 33.75 mg). Laboratory verification key RJ84B7RJVRC2. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re20-0327: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20-0327 on 2026-04-09 (HPLC purity 99.89%, measured content 24.88 mg). Laboratory verification key XB6NJXYQ3AH7. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10-0410: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0410 on 2026-04-09 (HPLC purity 99.77%, measured content 11.9 mg). Laboratory verification key NGASRZ5M2VNM. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Fri, Mar 27, 2026

Certificate published
PT-141 batch CS-pt10-0316: certificate published
Janoshik Analytical analysed PT-141 batch CS-pt10-0316 on 2026-03-27 (HPLC purity 99.70%, measured content 13.62 mg). Laboratory verification key FRRU1LP7L55M. The certificate is published at https://lyravital.com/coa/pt-141.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Kisspeptin-10 batch CS-ki10-0316: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki10-0316 on 2026-03-27 (HPLC purity 99.85%, measured content 13.23 mg). Laboratory verification key TJ7GL1C918TR. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glow Blend batch CS-gw70-0316: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw70-0316 on 2026-03-27 (measured content 58.88 mg). Laboratory verification key ECE3NJXM1DQD. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →

Tue, Mar 24, 2026

Certificate published
Ipamorelin batch CS-ip10-0313: certificate published
Janoshik Analytical analysed Ipamorelin batch CS-ip10-0313 on 2026-03-24 (HPLC purity 99.94%, measured content 10.96 mg). Laboratory verification key 7YE6S1T3TLAS. The certificate is published at https://lyravital.com/coa/ipamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
CJC-1295 (no DAC) batch CS-noda10-0313: certificate published
Janoshik Analytical analysed CJC-1295 (no DAC) batch CS-noda10-0313 on 2026-03-24 (HPLC purity 99.90%, measured content 10.91 mg). Laboratory verification key X8DBTAIR3MPB. The certificate is published at https://lyravital.com/coa/cjc-1295.
Source: Janoshik Analytical→ · Certificate history →

Wed, Mar 18, 2026

Certificate published
Retatrutide batch CS-re10-0309: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-0309 on 2026-03-18 (HPLC purity 99.73%, measured content 11.69 mg). Laboratory verification key C2J8XAT2DH42. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
MOTS-c batch CS-mc10-0309: certificate published
Janoshik Analytical analysed MOTS-c batch CS-mc10-0309 on 2026-03-18 (HPLC purity 99.44%, measured content 11.89 mg). Laboratory verification key 4XCF8N1S1ZIU. The certificate is published at https://lyravital.com/coa/mots-c.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu50-0309: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu50-0309 on 2026-03-18 (HPLC purity 99.78%, measured content 60.04 mg). Laboratory verification key F8MIBZFZW3YP. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10-0309: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0309 on 2026-03-18 (HPLC purity 99.79%, measured content 11.21 mg). Laboratory verification key VXXPES78PYD3. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Mon, Mar 16, 2026

Certificate published
TB-500 batch CS-tb10-0228: certificate published
Janoshik Analytical analysed TB-500 batch CS-tb10-0228 on 2026-03-16 (HPLC purity 99.81%, measured content 11.39 mg). Laboratory verification key Y8MRNBM7TCJE. The certificate is published at https://lyravital.com/coa/tb-500.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
NAD+ batch CS-na500-0228: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0228 on 2026-03-16 (measured content 576.91 mg). Laboratory verification key VNBAMYPHSC2H. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Fri, Mar 13, 2026

Certificate published
Tirzepatide batch CS-ze30-0228: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze30-0228 on 2026-03-13 (HPLC purity 99.82%, measured content 33.52 mg). Laboratory verification key VIDV81QEQRN9. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re20-0228: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20-0228 on 2026-03-13 (HPLC purity 99.83%, measured content 23.92 mg). Laboratory verification key G5JIKFXA1F1E. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Feb 20, 2026

Certificate published
AOD-9604 batch CS-ad5-0202: certificate published
Janoshik Analytical analysed AOD-9604 batch CS-ad5-0202 on 2026-02-20 (HPLC purity 99.08%, measured content 5.84 mg). Laboratory verification key TCCS5CITCRME. The certificate is published at https://lyravital.com/coa/aod-9604.
Source: Janoshik Analytical→ · Certificate history →

Wed, Feb 18, 2026

Certificate published
5-Amino-1MQ batch CS-5aq10-0203: certificate published
Janoshik Analytical analysed 5-Amino-1MQ batch CS-5aq10-0203 on 2026-02-18 (measured content 11.17 mg). Laboratory verification key C9V1MI5XUWNK. The certificate is published at https://lyravital.com/coa/5-amino-1mq.
Source: Janoshik Analytical→ · Certificate history →

Mon, Feb 16, 2026

Certificate published
SS-31 batch CS-s310-0205: certificate published
Janoshik Analytical analysed SS-31 batch CS-s310-0205 on 2026-02-16 (HPLC purity 99.69%, measured content 13.65 mg). Laboratory verification key HUZY3EHVW1TI. The certificate is published at https://lyravital.com/coa/ss-31.
Source: Janoshik Analytical→ · Certificate history →

Tue, Feb 10, 2026

Certificate published
Tirzepatide batch CS-ze10-0202: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze10-0202 on 2026-02-10 (HPLC purity 99.69%, measured content 12.08 mg). Laboratory verification key AI69BGIJAFHV. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Feb 6, 2026

Certificate published
NAD+ batch CS-na500-0126: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-0126 on 2026-02-06 (measured content 549.93 mg). Laboratory verification key QUFY2933BFWB. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Thu, Feb 5, 2026

Certificate published
Semax batch CS-sem10-0128: certificate published
Janoshik Analytical analysed Semax batch CS-sem10-0128 on 2026-02-05 (HPLC purity 99.57%, measured content 11.69 mg). Laboratory verification key QH8259YHGWUX. The certificate is published at https://lyravital.com/coa/semax.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Selank batch CS-sel10-0201: certificate published
Janoshik Analytical analysed Selank batch CS-sel10-0201 on 2026-02-05 (HPLC purity 99.80%, measured content 13 mg). Laboratory verification key JYXRKFGEL45Q. The certificate is published at https://lyravital.com/coa/selank.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re10-0126: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-0126 on 2026-02-05 (HPLC purity 99.41%, measured content 10.92 mg). Laboratory verification key AXV4HY7JOWK. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
PT-141 batch CS-pt10-0126: certificate published
Janoshik Analytical analysed PT-141 batch CS-pt10-0126 on 2026-02-05 (HPLC purity 99.86%, measured content 11.86 mg). Laboratory verification key SOICFP35P8F7. The certificate is published at https://lyravital.com/coa/pt-141.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu100-0201: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100-0201 on 2026-02-05 (HPLC purity 99.76%, measured content 118.71 mg). Laboratory verification key YAJZY6Q1X3S5. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ep10-0201: certificate published
Janoshik Analytical analysed Epitalon batch CS-ep10-0201 on 2026-02-05 (HPLC purity 99.77%, measured content 10.73 mg). Laboratory verification key 7VD9FZMJKLBS. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Cagrilintide batch CS-cag10-0126: certificate published
Janoshik Analytical analysed Cagrilintide batch CS-cag10-0126 on 2026-02-05 (HPLC purity 99.94%, measured content 11.97 mg). Laboratory verification key FCY4UX1U1L4B. The certificate is published at https://lyravital.com/coa/cagrilintide.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jan 28, 2026

Certificate published
MOTS-c batch CS-mc10-0120: certificate published
Janoshik Analytical analysed MOTS-c batch CS-mc10-0120 on 2026-01-28 (HPLC purity 99.35%, measured content 12.65 mg). Laboratory verification key NLVG26FYDJS6. The certificate is published at https://lyravital.com/coa/mots-c.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jan 26, 2026

Certificate published
Retatrutide batch CS-re20-0117: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20-0117 on 2026-01-26 (HPLC purity 99.77%, measured content 22.54 mg). Laboratory verification key IHTPMBUQCAD6. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ep50-0117: certificate published
Janoshik Analytical analysed Epitalon batch CS-ep50-0117 on 2026-01-26 (HPLC purity 99.50%, measured content 49.26 mg). Laboratory verification key YK69S7LJE4QG. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →

Fri, Jan 23, 2026

Certificate published
CJC-1295 (no DAC) batch CS-noda10-0116: certificate published
Janoshik Analytical analysed CJC-1295 (no DAC) batch CS-noda10-0116 on 2026-01-23 (HPLC purity 99.75%, measured content 12.85 mg). Laboratory verification key 8Y2LALJEDEFZ. The certificate is published at https://lyravital.com/coa/cjc-1295.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10-0116: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10-0116 on 2026-01-23 (HPLC purity 99.67%, measured content 11.49 mg). Laboratory verification key ILNISCIQ4AN3. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Thu, Jan 22, 2026

Certificate published
Semaglutide batch CS-se5-0116: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se5-0116 on 2026-01-22 (HPLC purity 99.25%, measured content 6.05 mg). Laboratory verification key 6QZK8LJRVPDF. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re30-0116: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re30-0116 on 2026-01-22 (HPLC purity 99.81%, measured content 34.32 mg). Laboratory verification key Q7F6UUXGLXEE. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jan 19, 2026

Certificate published
Tesamorelin batch CS-te10-0111: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te10-0111 on 2026-01-19 (HPLC purity 99.70%, measured content 11.41 mg). Laboratory verification key GI8BTN1JNPFL. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
TB-500 batch CS-tb10-0111: certificate published
Janoshik Analytical analysed TB-500 batch CS-tb10-0111 on 2026-01-19 (HPLC purity 99.33%, measured content 11.61 mg). Laboratory verification key 5S7D9CNI5LQZ. The certificate is published at https://lyravital.com/coa/tb-500.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Kisspeptin-10 batch CS-ki10-0111: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki10-0111 on 2026-01-19 (HPLC purity 99.69%, measured content 12.32 mg). Laboratory verification key 7JXTT3A6CUUF. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →

Fri, Jan 16, 2026

Certificate published
Wolverine Blend batch CS-t/b55-0108: certificate published
Janoshik Analytical analysed Wolverine Blend batch CS-t/b55-0108 on 2026-01-16 (measured content 5.8 mg). Laboratory verification key JSHPD2NKL2D1. The certificate is published at https://lyravital.com/coa/wolverine-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Tirzepatide batch CS-ze30-0108: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze30-0108 on 2026-01-16 (HPLC purity 99.83%, measured content 33.17 mg). Laboratory verification key 42YI18HKJKFG. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Ipamorelin batch CS-ip10-0108: certificate published
Janoshik Analytical analysed Ipamorelin batch CS-ip10-0108 on 2026-01-16 (HPLC purity 99.78%, measured content 10.31 mg). Laboratory verification key SHW3ZUW84BYS. The certificate is published at https://lyravital.com/coa/ipamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
IGF-1 LR3 batch CS-IG1-0105: certificate published
Janoshik Analytical analysed IGF-1 LR3 batch CS-IG1-0105 on 2026-01-16 (HPLC purity 98.59%, measured content 1.12 mg). Laboratory verification key T7RWAWUBTFEZ. The certificate is published at https://lyravital.com/coa/igf-1-lr3.
Source: Janoshik Analytical→ · Certificate history →

Mon, Jan 12, 2026

Certificate published
Thymosin Alpha-1 batch CS-ta110-1231: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-ta110-1231 on 2026-01-12 (HPLC purity 99.76%, measured content 11.37 mg). Laboratory verification key D13Z3LYE9783. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →

Thu, Jan 8, 2026

Certificate published
Retatrutide batch CS-re20-1225: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20-1225 on 2026-01-08 (HPLC purity 99.47%, measured content 24.19 mg). Laboratory verification key KS6XAF3GSIQ7. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu100-1225: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100-1225 on 2026-01-08 (HPLC purity 99.71%, measured content 122.97 mg). Laboratory verification key 38JTRYWMZQYI. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jan 7, 2026

Certificate published
GHK-Cu batch CS-gu50-1228: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu50-1228 on 2026-01-07 (HPLC purity 99.83%). Laboratory verification key TUNYEXEHW4Z3. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ep10-1228: certificate published
Janoshik Analytical analysed Epitalon batch CS-ep10-1228 on 2026-01-07 (HPLC purity 99.33%, measured content 10.07 mg). Laboratory verification key TGR2CPB2ZABH. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →

Tue, Jan 6, 2026

Certificate published
Retatrutide batch CS-re10-1220: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10-1220 on 2026-01-06 (HPLC purity 99.68%, measured content 11.8 mg). Laboratory verification key QW953C1165GN. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Jan 2, 2026

Certificate published
NAD+ batch CS-na500-1218: certificate published
Janoshik Analytical analysed NAD+ batch CS-na500-1218 on 2026-01-02 (measured content 534.68 mg). Laboratory verification key KBXBYK1QYWGE. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Tue, Dec 16, 2025

Certificate published
Tirzepatide batch CS-ze101208: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze101208 on 2025-12-16 (HPLC purity 99.67%, measured content 11.58 mg). Laboratory verification key SHU34JQYHKT4. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Dec 5, 2025

Certificate published
Semaglutide batch CS-se201128: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se201128 on 2025-12-05 (HPLC purity 99.78%, measured content 22.7 mg). Laboratory verification key NQL69HFVVKED. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semaglutide batch CS-se101128: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se101128 on 2025-12-05 (HPLC purity 99.47%, measured content 11.85 mg). Laboratory verification key 6A7PDZU8BG5L. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semaglutide batch CS-se51128: certificate published
Janoshik Analytical analysed Semaglutide batch CS-se51128 on 2025-12-05 (HPLC purity 99.09%, measured content 5.93 mg). Laboratory verification key RE2GJEAYTJJQ. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →

Mon, Dec 1, 2025

Certificate published
Tirzepatide batch CS-ze201124: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze201124 on 2025-12-01 (HPLC purity 99.72%, measured content 23.92 mg). Laboratory verification key 1B34VNFXW8CS. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
KPV batch CS-kv101123: certificate published
Janoshik Analytical analysed KPV batch CS-kv101123 on 2025-12-01 (HPLC purity 99.67%, measured content 11.72 mg). Laboratory verification key ZJFV394W1YD3. The certificate is published at https://lyravital.com/coa/kpv.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glutathione batch CS-glu6001123: certificate published
Janoshik Analytical analysed Glutathione batch CS-glu6001123 on 2025-12-01 (HPLC purity 99.07%, measured content 680.56 mg). Laboratory verification key DBSBW8HBPMVD. The certificate is published at https://lyravital.com/coa/glutathione.
Source: Janoshik Analytical→ · Certificate history →

Tue, Nov 18, 2025

Certificate published
Retatrutide batch CS-re301107: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re301107 on 2025-11-18. Laboratory verification key CT72G2DYAIM1. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Thu, Nov 13, 2025

Certificate published
Selank batch CS-sn101026: certificate published
Janoshik Analytical analysed Selank batch CS-sn101026 on 2025-11-13 (HPLC purity 99.72%, measured content 12.91 mg). Laboratory verification key IY4H7QJ1PS3E. The certificate is published at https://lyravital.com/coa/selank.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu1001026: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu1001026 on 2025-11-13 (HPLC purity 99.72%, measured content 127.01 mg). Laboratory verification key LGB6XISNP8KP. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
GHK-Cu batch CS-gu501026: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu501026 on 2025-11-13 (HPLC purity 99.55%, measured content 65.21 mg). Laboratory verification key SY6WGGMECUK3. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →

Wed, Nov 12, 2025

Certificate published
SS-31 batch CS-s3101103: certificate published
Janoshik Analytical analysed SS-31 batch CS-s3101103 on 2025-11-12 (HPLC purity 99.60%, measured content 14.4 mg). Laboratory verification key 9SNK6J36617W. The certificate is published at https://lyravital.com/coa/ss-31.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
PT-141 batch CS-pt101105: certificate published
Janoshik Analytical analysed PT-141 batch CS-pt101105 on 2025-11-12 (HPLC purity 99.81%, measured content 10.71 mg). Laboratory verification key 7ZCM8PGIDF15. The certificate is published at https://lyravital.com/coa/pt-141.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glow Blend batch CS-gw701103: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw701103 on 2025-11-12 (measured content 64.48 mg). Laboratory verification key 1S3WD8DU8Y7L. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc101103: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc101103 on 2025-11-12 (HPLC purity 99.50%, measured content 12.78 mg). Laboratory verification key 1L6BLJZN8VN5. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Tue, Nov 11, 2025

Certificate published
Tirzepatide batch CS-ze301026: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze301026 on 2025-11-11 (HPLC purity 99.76%, measured content 34.09 mg). Laboratory verification key MLME4M7KTQTV. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re101026: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re101026 on 2025-11-11 (HPLC purity 99.29%, measured content 10.96 mg). Laboratory verification key DUSQS5RZD4V6. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Fri, Oct 31, 2025

Certificate published
MOTS-c batch CS-mc101021: certificate published
Janoshik Analytical analysed MOTS-c batch CS-mc101021 on 2025-10-31 (HPLC purity 99.41%, measured content 11.54 mg). Laboratory verification key 3K8V29NK72UJ. The certificate is published at https://lyravital.com/coa/mots-c.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
IGF-1 LR3 batch CS-ilr11022: certificate published
Janoshik Analytical analysed IGF-1 LR3 batch CS-ilr11022 on 2025-10-31 (HPLC purity 99.65%, measured content 1.15 mg). Laboratory verification key Q18UL95W54IH. The certificate is published at https://lyravital.com/coa/igf-1-lr3.
Source: Janoshik Analytical→ · Certificate history →

Thu, Oct 30, 2025

Certificate published
Thymosin Alpha-1 batch CS-ta1101018: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-ta1101018 on 2025-10-30 (HPLC purity 99.82%, measured content 11.86 mg). Laboratory verification key 8U6VCGFGGCK4. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Tesamorelin batch CS-te101021: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te101021 on 2025-10-30 (HPLC purity 99.56%, measured content 12.54 mg). Laboratory verification key 7CEGCFAH1GKQ. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ei501018: certificate published
Janoshik Analytical analysed Epitalon batch CS-ei501018 on 2025-10-30 (HPLC purity 99.69%, measured content 52.12 mg). Laboratory verification key YRXVJAKI8Y7R. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
DSIP batch CS-dp51021: certificate published
Janoshik Analytical analysed DSIP batch CS-dp51021 on 2025-10-30 (HPLC purity 99.63%, measured content 6.1 mg). Laboratory verification key CWQJGMYTV1N1. The certificate is published at https://lyravital.com/coa/dsip.
Source: Janoshik Analytical→ · Certificate history →

Mon, Oct 27, 2025

Certificate published
Wolverine Blend batch CS-bt101018: certificate published
Janoshik Analytical analysed Wolverine Blend batch CS-bt101018 on 2025-10-27 (measured content 5.89 mg). Laboratory verification key JOGV5E3EJ6YI. The certificate is published at https://lyravital.com/coa/wolverine-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
TB-500 batch CS-t5101018: certificate published
Janoshik Analytical analysed TB-500 batch CS-t5101018 on 2025-10-27 (HPLC purity 99.77%, measured content 11.98 mg). Laboratory verification key YF5633UIFV8W. The certificate is published at https://lyravital.com/coa/tb-500.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semax batch CS-sa101018: certificate published
Janoshik Analytical analysed Semax batch CS-sa101018 on 2025-10-27 (HPLC purity 99.53%, measured content 11.85 mg). Laboratory verification key P5BB2MI3CGAK. The certificate is published at https://lyravital.com/coa/semax.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
NAD+ batch CS-nd5001018: certificate published
Janoshik Analytical analysed NAD+ batch CS-nd5001018 on 2025-10-27 (measured content 546.37 mg). Laboratory verification key 4LGVJEDKMKBC. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Cagrilintide batch CS-ca101008: certificate published
Janoshik Analytical analysed Cagrilintide batch CS-ca101008 on 2025-10-27 (measured content 11.39 mg). Laboratory verification key BVI1VHAEFUIC. The certificate is published at https://lyravital.com/coa/cagrilintide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
AOD-9604 batch CS-ad51018: certificate published
Janoshik Analytical analysed AOD-9604 batch CS-ad51018 on 2025-10-27 (HPLC purity 99.86%, measured content 5.09 mg). Laboratory verification key ZE4YJ8SRSFGU. The certificate is published at https://lyravital.com/coa/aod-9604.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
5-Amino-1MQ batch CS-5aq101018: certificate published
Janoshik Analytical analysed 5-Amino-1MQ batch CS-5aq101018 on 2025-10-27 (measured content 11.21 mg). Laboratory verification key FKJ2GHCS2LTW. The certificate is published at https://lyravital.com/coa/5-amino-1mq.
Source: Janoshik Analytical→ · Certificate history →

Thu, Oct 23, 2025

Certificate published
Tirzepatide batch CS-ze101018: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze101018 on 2025-10-23 (HPLC purity 99.19%, measured content 11.89 mg). Laboratory verification key V21RPTMQ3ZNP. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re201018: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re201018 on 2025-10-23 (HPLC purity 99.60%, measured content 22.79 mg). Laboratory verification key ITLH54Y3G7H3. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Wed, Oct 22, 2025

Certificate published
Kisspeptin-10 batch CS-ki101012: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki101012 on 2025-10-22 (HPLC purity 99.55%, measured content 11.92 mg). Laboratory verification key 3H8L3ZNAXE56. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →

Mon, Oct 20, 2025

Certificate published
Epitalon batch CS-ei: certificate published
Janoshik Analytical analysed Epitalon batch CS-ei on 2025-10-20 (HPLC purity 99.35%, measured content 12.52 mg). Laboratory verification key DUA4W71DTGMI. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →

Thu, Sep 25, 2025

Certificate published
GHK-Cu batch CS-gu100922: certificate published
Janoshik Analytical analysed GHK-Cu batch CS-gu100922 on 2025-09-25 (HPLC purity 99.85%, measured content 96.88 mg). Laboratory verification key IVBJX94N8MZD. The certificate is published at https://lyravital.com/coa/ghk-cu.
Source: Janoshik Analytical→ · Certificate history →

Wed, Sep 24, 2025

Certificate published
Retatrutide batch CS-re10920: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re10920 on 2025-09-24 (HPLC purity 99.49%, measured content 11.77 mg). Laboratory verification key ZRAYMBQC4ET3. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Thu, Sep 18, 2025

Certificate published
Semaglutide batch CS-sg5916: certificate published
Janoshik Analytical analysed Semaglutide batch CS-sg5916 on 2025-09-18 (HPLC purity 99.38%, measured content 6.16 mg). Laboratory verification key I35YGKQ5P7WR. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Glow Blend batch CS-gw70916: certificate published
Janoshik Analytical analysed Glow Blend batch CS-gw70916 on 2025-09-18 (measured content 53.44 mg). Laboratory verification key R2XNGDIMSZP7. The certificate is published at https://lyravital.com/coa/glow-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
BPC-157 batch CS-bc10916: certificate published
Janoshik Analytical analysed BPC-157 batch CS-bc10916 on 2025-09-18 (HPLC purity 99.30%, measured content 10.82 mg). Laboratory verification key XTIWVCMSRESN. The certificate is published at https://lyravital.com/coa/bpc-157.
Source: Janoshik Analytical→ · Certificate history →

Mon, Sep 8, 2025

Certificate published
Tirzepatide batch CS-ze30908: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze30908 on 2025-09-08 (HPLC purity 99.67%, measured content 33.84 mg). Laboratory verification key P9H2YVTBA781. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re30908: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re30908 on 2025-09-08 (HPLC purity 99.74%, measured content 31.85 mg). Laboratory verification key EA4LUGXJQYTIE. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →

Tue, Sep 2, 2025

Certificate published
CJC-1295 (no DAC) batch CS- cnd10902: certificate published
Janoshik Analytical analysed CJC-1295 (no DAC) batch CS- cnd10902 on 2025-09-02 (HPLC purity 99.14%, measured content 11.4 mg). Laboratory verification key ATIXGWFCVBT1. The certificate is published at https://lyravital.com/coa/cjc-1295.
Source: Janoshik Analytical→ · Certificate history →

Fri, Aug 29, 2025

Certificate published
IGF-1 LR3 batch CS- ilr1825: certificate published
Janoshik Analytical analysed IGF-1 LR3 batch CS- ilr1825 on 2025-08-29 (HPLC purity 99.56%, measured content 1.01 mg). Laboratory verification key U89E5RSCCNVL. The certificate is published at https://lyravital.com/coa/igf-1-lr3.
Source: Janoshik Analytical→ · Certificate history →

Thu, Aug 21, 2025

Certificate published
Cagrilintide batch CS-ca10808: certificate published
Janoshik Analytical analysed Cagrilintide batch CS-ca10808 on 2025-08-21 (measured content 12.41 mg). Laboratory verification key 3FIGHTEL1BJP. The certificate is published at https://lyravital.com/coa/cagrilintide.
Source: Janoshik Analytical→ · Certificate history →

Wed, Aug 20, 2025

Certificate published
TB-500 batch CS- t510820: certificate published
Janoshik Analytical analysed TB-500 batch CS- t510820 on 2025-08-20 (HPLC purity 99.86%, measured content 12.08 mg). Laboratory verification key C747LJTQUPIG. The certificate is published at https://lyravital.com/coa/tb-500.
Source: Janoshik Analytical→ · Certificate history →

Fri, Aug 15, 2025

Certificate published
SS-31 batch CS- s310805: certificate published
Janoshik Analytical analysed SS-31 batch CS- s310805 on 2025-08-15 (HPLC purity 99.89%, measured content 12.72 mg). Laboratory verification key MC9ETS7EZQ16. The certificate is published at https://lyravital.com/coa/ss-31.
Source: Janoshik Analytical→ · Certificate history →

Thu, Aug 14, 2025

Certificate published
Semax batch CS-sa10815: certificate published
Janoshik Analytical analysed Semax batch CS-sa10815 on 2025-08-14 (HPLC purity 99.92%, measured content 11.93 mg). Laboratory verification key XEUP114T9XRT. The certificate is published at https://lyravital.com/coa/semax.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Selank batch CS-sn10815: certificate published
Janoshik Analytical analysed Selank batch CS-sn10815 on 2025-08-14 (HPLC purity 99.77%, measured content 11.05 mg). Laboratory verification key M733TLGAS2XX. The certificate is published at https://lyravital.com/coa/selank.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Retatrutide batch CS-re20815: certificate published
Janoshik Analytical analysed Retatrutide batch CS-re20815 on 2025-08-14 (HPLC purity 99.54%, measured content 25.59 mg). Laboratory verification key LGSBRIZV68VM. The certificate is published at https://lyravital.com/coa/retatrutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
NAD+ batch CS- nd500805: certificate published
Janoshik Analytical analysed NAD+ batch CS- nd500805 on 2025-08-14 (measured content 584.12 mg). Laboratory verification key QV7S7TJGTLR1. The certificate is published at https://lyravital.com/coa/nad-plus.
Source: Janoshik Analytical→ · Certificate history →

Mon, Aug 11, 2025

Certificate published
Tirzepatide batch CS-ze10801: certificate published
Janoshik Analytical analysed Tirzepatide batch CS-ze10801 on 2025-08-11 (HPLC purity 99.15%, measured content 11.41 mg). Laboratory verification key GQVERL8CRTXH. The certificate is published at https://lyravital.com/coa/tirzepatide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Tesamorelin batch CS-te10801: certificate published
Janoshik Analytical analysed Tesamorelin batch CS-te10801 on 2025-08-11 (HPLC purity 99.28%, measured content 10.71 mg). Laboratory verification key BMRGJI4L9MXD. The certificate is published at https://lyravital.com/coa/tesamorelin.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Semaglutide batch CS-sg10801: certificate published
Janoshik Analytical analysed Semaglutide batch CS-sg10801 on 2025-08-11 (HPLC purity 99.51%, measured content 11.42 mg). Laboratory verification key ZRIE6BTDVSXI. The certificate is published at https://lyravital.com/coa/semaglutide.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
MOTS-c batch CS-mc10801: certificate published
Janoshik Analytical analysed MOTS-c batch CS-mc10801 on 2025-08-11 (HPLC purity 99.29%, measured content 11.98 mg). Laboratory verification key LA896ST2DGYF. The certificate is published at https://lyravital.com/coa/mots-c.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Kisspeptin-10 batch CS-ki10801: certificate published
Janoshik Analytical analysed Kisspeptin-10 batch CS-ki10801 on 2025-08-11 (HPLC purity 99.79%, measured content 11.47 mg). Laboratory verification key TWJV6JK2LHA1. The certificate is published at https://lyravital.com/coa/kisspeptin-10.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Ipamorelin batch CS-ir10801: certificate published
Janoshik Analytical analysed Ipamorelin batch CS-ir10801 on 2025-08-11 (HPLC purity 99.11%, measured content 11.64 mg). Laboratory verification key AB3ZUC1VE8GH. The certificate is published at https://lyravital.com/coa/ipamorelin.
Source: Janoshik Analytical→ · Certificate history →

Thu, Jul 31, 2025

Certificate published
Wolverine Blend batch CS-bt55720: certificate published
Janoshik Analytical analysed Wolverine Blend batch CS-bt55720 on 2025-07-31 (measured content 6.12 mg). Laboratory verification key EWZBEDXK9Q3U. The certificate is published at https://lyravital.com/coa/wolverine-blend.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Thymosin Alpha-1 batch CS-bt55720: certificate published
Janoshik Analytical analysed Thymosin Alpha-1 batch CS-bt55720 on 2025-07-31 (HPLC purity 99.09%, measured content 12.57 mg). Laboratory verification key AID56ZQPXEVF. The certificate is published at https://lyravital.com/coa/thymosin-alpha-1.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
Epitalon batch CS-ei: certificate published
Janoshik Analytical analysed Epitalon batch CS-ei on 2025-07-31 (HPLC purity 99.30%, measured content 13.22 mg). Laboratory verification key YN1JPQ354P39. The certificate is published at https://lyravital.com/coa/epitalon.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
AOD-9604 batch CS-ad5720: certificate published
Janoshik Analytical analysed AOD-9604 batch CS-ad5720 on 2025-07-31 (HPLC purity 99.11%, measured content 4.52 mg). Laboratory verification key UMGCC94RWMMV. The certificate is published at https://lyravital.com/coa/aod-9604.
Source: Janoshik Analytical→ · Certificate history →

Wed, Jul 30, 2025

Certificate published
PT-141 batch CS-p110728: certificate published
Janoshik Analytical analysed PT-141 batch CS-p110728 on 2025-07-30 (HPLC purity 99.95%, measured content 12.84 mg). Laboratory verification key 8XTB2ANZXMUD. The certificate is published at https://lyravital.com/coa/pt-141.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
DSIP batch CS-dp5728: certificate published
Janoshik Analytical analysed DSIP batch CS-dp5728 on 2025-07-30 (HPLC purity 99.46%, measured content 5.37 mg). Laboratory verification key KMWVE6RQERMW4. The certificate is published at https://lyravital.com/coa/dsip.
Source: Janoshik Analytical→ · Certificate history →
Certificate published
5-Amino-1MQ batch CS-5aq10728: certificate published
Janoshik Analytical analysed 5-Amino-1MQ batch CS-5aq10728 on 2025-07-30 (measured content 10.27 mg). Laboratory verification key AVR7R6G1DKQF. The certificate is published at https://lyravital.com/coa/5-amino-1mq.
Source: Janoshik Analytical→ · Certificate history →

Fri, Jul 25, 2025

Certificate published
KPV batch CS-kv10715: certificate published
Janoshik Analytical analysed KPV batch CS-kv10715 on 2025-07-25 (HPLC purity 99.46%, measured content 14.74 mg). Laboratory verification key ZDASPRZNQQU2. The certificate is published at https://lyravital.com/coa/kpv.
Source: Janoshik Analytical→ · Certificate history →

How to read this page

What is Batch Watch?: A dated record of independent research-peptide test results, vendor status changes and newly certified batches, assembled automatically from named public records and published as they appear. Each entry links the record it quotes so it can be checked without trusting this site.
Where do the test results come from?: Failed tests and daily counts are quoted from Finnrick, an independent peptide-testing platform that publishes its laboratory results and the certificate behind each one under a stated methodology. Vendor status lines are quoted from the same record. Lyra Vital's own entries are our certificates from Janoshik Analytical, each carrying the laboratory's verification key.
Does a failed test mean a vendor is bad?: No. It means one sample, on one date, did not meet the standard the testing platform applies. Vendors can and do pass other tests, and the platform publishes corrections when it changes a result. Read the linked record, including the vendor's full history, before drawing any conclusion.
Why does Lyra Vital publish other vendors' results?: Because the question every buyer actually has is whether a specific batch from a specific vendor is what it claims to be, right now, and the answer lives in public records that are scattered and easy to miss. Our own certificates sit in the same list, under the same rules, which is the only honest way to publish it.

Test results attributed to Finnrick are Finnrick’s published data under its public Purity Focus methodology; the laboratory certificate behind each is on their site, as are their corrections. Machine-readable feed: RSS. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.

Batch Watch

Sun, Sep 20, 2026

Retatrutide from XTP did not meet Finnrick's public standard

Retatrutide from Apollo Peptide Sciences did not meet Finnrick's public standard

Semaglutide from Apollo Peptide Sciences did not meet Finnrick's public standard

Ipamorelin from Hydro Research did not meet Finnrick's public standard

CJC-1295 from Hydro Research did not meet Finnrick's public standard

BPC-157 from Hydro Research did not meet Finnrick's public standard

BPC-157 from Reta-Peptide did not meet Finnrick's public standard

BPC-157 from Apollo Peptide Sciences did not meet Finnrick's public standard

Tirzepatide from Nexaph did not meet Finnrick's public standard

Retatrutide from XTP did not meet Finnrick's public standard

Finnrick published 16 tests on 2026-09-20: 6 met the public standard, 10 did not

Wed, Sep 16, 2026

Finnrick published 1 test on 2026-09-16: 0 met the public standard, 0 did not

Mon, Sep 14, 2026

Finnrick published 5 tests on 2026-09-14: 5 met the public standard, 0 did not

Thu, Sep 10, 2026

Tirzepatide from LP Peptide did not meet Finnrick's public standard

Tesamorelin from Heman Peptide HM did not meet Finnrick's public standard

Tesamorelin from Yiwu Aozuo Trading Co did not meet Finnrick's public standard

MOTS-c from Heman Peptide HM did not meet Finnrick's public standard

TB-500 from HK Peptides did not meet Finnrick's public standard

Tirzepatide from Mia Peptide did not meet Finnrick's public standard

Ipamorelin from Yiwu Aozuo Trading Co did not meet Finnrick's public standard

Tesamorelin from EHZ Peptides did not meet Finnrick's public standard

NAD+ from Heman Peptide HM did not meet Finnrick's public standard

Tirzepatide from Kerui Peptide HongKong did not meet Finnrick's public standard

Tesamorelin from Nexaph did not meet Finnrick's public standard

Finnrick published 17 tests on 2026-09-10: 6 met the public standard, 11 did not

Wed, Sep 9, 2026

Retatrutide from Novabio Research did not meet Finnrick's public standard

Retatrutide from XTP did not meet Finnrick's public standard

Retatrutide from Changsha Caoquan Technology did not meet Finnrick's public standard

Retatrutide from Peptide Healths did not meet Finnrick's public standard

Retatrutide from LP Peptide did not meet Finnrick's public standard

GHK-Cu from Peptide Partners did not meet Finnrick's public standard

GHK-Cu from EHZ Peptides did not meet Finnrick's public standard

Retatrutide from HK Peptides did not meet Finnrick's public standard

BPC-157 from Yabang Peptide did not meet Finnrick's public standard

CJC-1295 from LiliPeptide did not meet Finnrick's public standard

Retatrutide from Lumira did not meet Finnrick's public standard

Retatrutide from Yabang Peptide did not meet Finnrick's public standard

Retatrutide from LP Peptide did not meet Finnrick's public standard

GHK-Cu from LP Peptide did not meet Finnrick's public standard

Retatrutide from Shanghai Leader Peptide Biotechnology did not meet Finnrick's public standard

Finnrick published 44 tests on 2026-09-09: 29 met the public standard, 15 did not

Tue, Sep 8, 2026

Retatrutide from Novabio Research did not meet Finnrick's public standard

Finnrick published 13 tests on 2026-09-08: 12 met the public standard, 1 did not

Mon, Sep 7, 2026

Retatrutide from Rayshine Peptide Biochemicals did not meet Finnrick's public standard

Retatrutide from Yiwu Beigong did not meet Finnrick's public standard

Retatrutide from Zztai Peptide did not meet Finnrick's public standard

Retatrutide from Norco did not meet Finnrick's public standard

Retatrutide from NutriPeptix did not meet Finnrick's public standard

Retatrutide from Noble Dragons did not meet Finnrick's public standard

Tirzepatide from Lumira did not meet Finnrick's public standard

Tirzepatide from Zhengzhou Lan Yun Cosmetic Trading did not meet Finnrick's public standard

Retatrutide from Zhengzhou Lan Yun Cosmetic Trading did not meet Finnrick's public standard

Retatrutide from Norco did not meet Finnrick's public standard

Finnrick published 26 tests on 2026-09-07: 15 met the public standard, 10 did not

Sat, Sep 5, 2026

Tesamorelin from Laicuinuo LCN did not meet Finnrick's public standard

Retatrutide from Laicuinuo LCN did not meet Finnrick's public standard

Finnrick published 18 tests on 2026-09-05: 15 met the public standard, 2 did not

Fri, Sep 4, 2026

Tirzepatide from Core Peptides did not meet Finnrick's public standard

TB-500 from Bionexis Peptides did not meet Finnrick's public standard

TB-500 from Bionexis Peptides did not meet Finnrick's public standard

BPC-157 from Peptide Crafters did not meet Finnrick's public standard

Sermorelin from Qing Li Peptide did not meet Finnrick's public standard

GHK-Cu from Super panda peptide did not meet Finnrick's public standard

GHK-Cu from Bionexis Peptides did not meet Finnrick's public standard

Sermorelin from Shanxi Qianyecao Biotech QYC did not meet Finnrick's public standard

MOTS-c from ZePeptide did not meet Finnrick's public standard

Ipamorelin from Wuhan Wansheng Biotechnology did not meet Finnrick's public standard

Retatrutide from Mokemei Zhengzhou Biotechnology MKM did not meet Finnrick's public standard

KPV from Shanghai Baoju did not meet Finnrick's public standard

HGH from Lumira did not meet Finnrick's public standard